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Associat ion of Admission Plasma D-Dimer Concentrat ion with
Diagnosis and Outcome in Horses with Colic
C. Cesarini, L. Monreal, L. Armengou, M.A´. Delgado, J. Rı´os, and E. Jose-Cunilleras
Background: Coagulopathies detected in horses with gastrointestinal problems seem to be associated with poor outcome.
Plasma D-Dimer concentration is a sensitive test for assessing coagulopathies.
Hypothesis: Plasma D-Dimer concentration tested on admission is related to diagnosis and outcome in horses with colic.
Animals: Four hundred and ninety three horses referred for evaluation of abdominal pain.
Methods: Prospective observational clinical study. Horses were grouped according to diagnosis (medical and surgical
intestinal obstructions, ischemic disorders with and without intestinal resection, enteritis, peritonitis), outcome (survivors, non-
survivors), and number of coagulopathies (normal proﬁle, 1 or 2 coagulopathies, subclinical disseminated intravascular
coagulation [DIC]). Blood samples were collected on admission and plasma D-Dimer concentration, clotting times (PT and
aPTT), and antithrombin activity were determined. Positive likelihood ratios (LR1) were calculated for evaluation of D-Dimer
cut-off values, which were later tested in a logistic regression model.
Results: Horses with enteritis or peritonitis had signiﬁcantly (Po .001) higher plasma D-Dimer concentrations and more
severe coagulopathies on admission than horses with other diagnoses. Nonsurvivors also had signiﬁcantly (P o .001) higher
plasma D-Dimer concentrations at presentation than did survivors, and those horses with subclinical DIC on presentation had
an odds ratio (OR) 8.6 (95% conﬁdence interval [CI], 3.3–22.5, P o .001) for nonsurvival. Finally, D-Dimer concentrations
44,000 ng/mL had a LR1 of 5.9 and an OR 8.8 (95% CI, 4.5–17.1, Po .001) for nonsurvival.
Conclusion and Clinical Importance: Plasma D-Dimer concentration measured on admission can be used to facilitate diag-
nosis and outcome prediction in horses with colic. A potential cut-off value for nonsurvival was found at approximately
4,000 ng/mL.
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H istorically, gastrointestinal (GI) disorders havebeen the most prevalent cause of coagulation dis-
orders in horses.1,2 In horses with acute abdominal pain,
coagulation problems are common and usually result in a
hypercoagulable state. This can progress to the more
severe disseminated intravascular coagulation (DIC),
resulting in a subsequent consumption coagulopathy.1–4
DIC is rarely clinically evident in horses with colic, al-
though it is possible to diagnose subclinical DIC based
on compatible clinicopathologic data.2,5
There is some evidence that the severity of the host in-
ﬂammatory response to an inciting event may be
extremely critical in the development of coagulopathy
and may play an important role in patient outcome.6
Ischemic or inﬂammatory GI problems and other disor-
ders resulting in endotoxemia and severe systemic
inﬂammatory response syndrome more commonly are
associated with marked hypercoagulation and may cause
DIC.2–4 A high percentage of horses with colitis (up to
36%) and ischemic lesions (up to 70%) have been re-
ported to be in DIC, especially those disorders that have
a poor prognosis, such as large colon volvulus.5–7 Addi-
tionally, approximately 40% of horses with ischemic and
inﬂammatory GI diseases of poor prognosis were found
to have massive ﬁbrin deposition in several organs at
necropsy consistent with microthrombosis and DIC.8
Thus, the severity of coagulopathies in horses with GI
disorders appears to be related to the diagnosis.
Furthermore, the severity of coagulopathies in horses
with GI problems also seems to be associated with poor
outcome.3,5,7,9,10 In horses with colitis, the odds of sur-
vival in a horse with subclinical DIC were decreased 8-
fold relative to horses without subclinical DIC.5 A study
of hemostatic proﬁles in horses with large colon volvulus
that underwent surgery concluded that there was an
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association between development of coagulopathy and
outcome, conﬁrming that horses with 4 of 6 abnormal
coagulation tests were more likely to be euthanized, and
those with 3 of 6 abnormal tests had a prolonged hospital
stay.7 Moreover, increases in morbidity and mortality
have been associated with alterations in the coagulation
and ﬁbrinolysis systems in horses with systemic dis-
ease.6,11 Other studies have demonstrated that rapid
detection and treatment of subclinical coagulopathies in
horses and humans decrease morbidity and mortality
associated with development of fulminant DIC.a,10,12,13
To make more valid prognostic assessments in colic
cases, many authors have evaluated the usefulness of in-
dividual variables taken on admission and during
hospitalization, including clinical and clinicopathological
data.3,9–11,14–29 Several of these studies included hemostat-
ic parameters and some have been found to be associated
with outcome, although results among studies were vari-
able and sometimes contradictory.a,3,9,11,20,21,23,29,30
Common tests to evaluate hemostasis in horses include
platelet count, prothrombin time (PT), activated partial
thromboplastin time (aPTT), antithrombin activity (AT),
ﬁbrinogen, ﬁbrin(ogen) degradation products, and D-
Dimer concentrations.b,3,5–7,9–11,21,23,29 Newly available
tests, such as mean platelet component (MPC) provided
by current CBC analyzers, also have shown to be useful to
detect platelet activation.31 Other hemostatic parameters
typically are not available for evaluation of the clinical
patient in a hospital setting.4,32
Plasma D-Dimer concentration is considered the most
sensitive test to diagnose thromboembolic disease and
DIC in humanmedicine, and it also has been shown to be
a good predictor of mortality.33 In horses, D-Dimers
have been found by our group to be a useful tool for de-
tection of hypercoagulable states in horses with colic and
septic foals during hospitalization.a,6,34,35 Furthermore,
a marked increase in plasma D-Dimer concentration has
been found to be associated with ischemic and inﬂamma-
tory GI disorders, and especially in horses with
peritonitis, when determined on presentation.a,c,35 Some
studies also have advocated the usefulness of plasma
D-Dimer concentration as a good prognostic aid in
horses with acute GI problems and recommend its deter-
mination for routine screening of colic patients upon
admission.c,21,35
The objectives of this study were to evaluate (1) the re-
lationship of admission plasma D-Dimer concentration
with the likelihood of survival in horses with several
types of colic, and (2) the association between admission
plasma D-Dimer concentration and other coagulation
proﬁle data with diagnosis and outcome in different
acute GI disorders.
Materials and Methods
Animals
Horses with colic admitted to the Equine Teaching Hospital of
Barcelona between March 2004 and September 2008 were included
in this prospective observational clinical study. Foals younger than
21 days, horses with concomitant inﬂammatory disorders not re-
lated to GI disease (eg, pneumonia) or liver disease, horses with 2 or
more GI disorders of similar severity (eg, ischemic and inﬂamma-
tory disorders), and horses with chronic disorders were excluded
from the study.
Horses were grouped according to diagnosis in 6 groups, includ-
ing medical and surgical intestinal obstructions, GI inﬂammatory
conditions, ischemic intestinal problems with or without intestinal
resection, and peritonitis. Horses with ischemic lesions were divided
into 2 groups because cases with more severe forms of ischemia and
those with prolonged ischemia (46 hours) are associated with more
severe coagulopathies that contribute to the death of the horse.36
Diagnosis was based on clinical history, complete physical exam-
ination, and results of complementary diagnostic tests (CBC,
plasma biochemistry, blood gas analysis, abdominal ultrasono-
graphy, and peritoneal ﬂuid analysis). Findings of abdominal
radiology, exploratory laparotomy, postmortem examination or
some combination of these were used for this classiﬁcation when-
ever they were performed. The medical obstructive group included
all horses with nonstrangulating, noninﬂammatory disorders of the
GI tract (such as impactions and large colon displacements) without
signs of intestinal devitalization, which resolved with medical ther-
apy (IV ﬂuids, enteral ﬂuids, laxatives), whereas the surgical
obstructive group comprised those that needed surgery (mainly
colon displacements). The enteritis group included horses with acute
inﬂammation of small intestine (duodenojejunitis) or large intestine
(colitis, typhlocolitis) or both diagnosed by compatible clinical signs
(eg, gastric reﬂux, diarrhea, fever), clinicopathological data (eg,
hypoalbuminemia, acid-base, and electrolyte imbalances) as well as
results of complementary examinations (abdominal ultrasound,
peritoneal ﬂuid analysis). The ischemic group without intestinal
resection included horses with strangulating GI lesions, such as
intestinal volvulus or torsion, epiploic entrapment, inguinal hernias,
and intussusceptions, where the affected intestinal portion was con-
sidered viable and subsequently had good recovery. Animals were
included in the ischemic group with intestinal resection when any
part of the affected bowel needed to be surgically removed. Finally,
the peritonitis group included horses with gastric or intestinal rup-
tures, as well as septic peritonitis (presence of intra- and
extracellular bacteria in peritoneal ﬂuid) caused by bowel devital-
ization but without rupture, intra-abdominal abscesses and other
causes.
Horses also were grouped according to outcome: survivors (horses
that were discharged from the hospital), nonsurvivors (horses that
died during hospitalization because of progressive worsening of dis-
ease or that were euthanized based on poor prognosis), and the
ﬁnancial restraint group (horses that did not receive the suitable
treatment for ﬁnancial or personal reasons). Horses that were either
euthanized or left the hospital without medical consent because of
economic restraints were not considered in outcome analysis.
Finally, a diagnosis of subclinical DIC was made when horses
had clinicopathological evidence of DIC (3 abnormal parameters
in the coagulation proﬁle) based on criteria used in the equine liter-
ature.5,6,37 For the purposes of this study, horses with 1 or 2
abnormal coagulation parameters were considered to have activa-
tion of the coagulation system.
Additionally, a group of 30 healthy horses was used as controls,
and included horses in regular training from a riding school near the
Teaching Hospital, controlled blood donors, and healthy mares (41
week postpartum) that had accompanied their hospitalized sick
foals.
Blood Sampling and Measured Parameters
On admission, blood samples were obtained by jugular veni-
puncture into 5mL tubes containing 3.8% sodium citrate by using a
vacutainer system.d Immediately after, blood samples were centri-
fuged at 1,000  g for 15 minutes, and plasma was frozen at –801C
until analysis. Plasma D-Dimer concentration, PT, aPTT, and
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AT were measured in duplicate for all samples, as reported in pre-
vious studies.a,c,6,34–36 Clotting times and AT were determined
to complement plasma D-Dimer concentrations and to allow
classiﬁcation of coagulation dysfunction. Coagulation tests were
considered abnormal when D-Dimer concentration was41,000 ng/
mL, PT4 15 seconds, aPTT4 65 seconds, and ATo 140%, based
on previous studies and reference values in our laboratory.a,c,6,35
Other useful hemostatic variables (ie, platelet count, MPC) were not
included in this study because after hours sampling prevented in-
surance of accurate determination in many cases. Also, ﬁbrinogen
concentration was not included because of its low sensitivity in as-
sessment of coagulopathies in colic horses.5,6,37 Plasma D-Dimer
concentration was determined using an immunoturbidimetere with
commercial reagents and controlsf; PT and aPTT were determined
with a semiautomatic coagulometerg with commercial reagents and
controlsh; and AT was determined with a chromogenic kiti in a
semiautomatic analyzer.j
Statistical Analysis
Results were expressed as frequencies and percentages for qual-
itative variables and median (interquartile range) for quantitative
variables. Univariate inferential analysis was performed by Fisher’s
exact test for categorical data or the Mann-Whitney U test for
quantitative variables. D-Dimer concentration was assessed by
means of the positive likelihood ratio (LR1) estimation for dying/
being euthanized, deﬁned as sensitivity/(1speciﬁcity), to obtain
different cut-off values. In general, values of LR1 higher than 5
indicate a moderate increase in the likelihood of the disease, and
values higher than 10 indicate a large and often conclusive likeli-
hood. An interval validation of these cut-off values also was
performed by means of logistic regression models. Several multi-
variate models were evaluated by the cut-off values obtained by
LR1, adding 1 of the other 3 hemostatic parameters tested (PT,
aPTT, or AT) in this statistical study. D-Dimer concentration was
included as a ﬁxed factor in all models for different cut-off values
(2,000, 3,000, 4,000, 5,000, and 5,500 ng/mL) in order to assess the
inﬂuence of the 4 hemostatic parameters as covariables. An estima-
tion of the risk of death by number of abnormal coagulation
parameters was performed by a univariate logistic regression model.
P values  0.05 were considered statistically signiﬁcant. With the
aim of not inﬂating type I error rate in subtype diagnostic analysis,
comparisons with the control group were only performed by global
type (obstructions or ischemias) when nonsigniﬁcant relations were
observed between subtype of diagnosis (medical versus surgical
obstructions, and ischemias with versus without intestinal resec-
tion). Statistical analysis was performed by the SPSS 15.0 package.k
Results
Of all horses admitted for colic during the study pe-
riod, 493 horses met the inclusion criteria and were
included in the study. The sex distribution was 174
females (35.5%), 139 intact males (28.4%), and 177
geldings (36.1%). No sex information was available for
3 horses. The median age (interquartile range) of the
population was 8 years (5–12 years). No age information
was available for 9 horses. One hundred seventy-four
horses (35.6%) were Andalusians, 122 horses (24.9%)
were crossbred, 28 (5.7%) Arabians, 26 (5.3%) Warm-
bloods, 24 (4.9%) ponies, 14 (2.9%) and Draft breeds,
and the remaining 97 horses were a mixture of different
breeds. No breed information was available for 4 horses.
Diagnoses included 229 horses (46.5%) with medical
obstructions, 74 (15%) surgical obstructions, 74 (15%)
inﬂammatory problems, 33 (6.7%) ischemic lesions with-
out intestinal resection, 51 (10.3%) ischemic lesions with
intestinal resection, and 32 (6.5%) horses with peritonitis.
Of the 493 horses, 387 (78.5%) survived, 80 (16.2%)
died or were euthanized because of poor prognosis, 23
(4.7%) were euthanized because of ﬁnancial constraints,
and 3 horses (0.6%) left the hospital against medical
advice. The outcome distribution of horses with different
diagnoses is shown in Table 1.
Hemostatic Proﬁle in the Different Diagnostic Groups
Results of coagulation proﬁle data by diagnostic
group are presented in Tables 2 and 3. On admission, D-
Dimer concentration was markedly and signiﬁcantly (P
o .001) higher in inﬂammatory diseases (enteritis and
peritonitis groups) compared with controls. Despite be-
ing also increased in the ischemic group that needed
resection, concentrations did not reach signiﬁcant differ-
ences. Clotting times were mildly but signiﬁcantly
prolonged in all colic groups, and AT showed mild differ-
ences in both obstructive groups when compared with
controls. Comparing horses with medical versus surgical
obstructive problems, no signiﬁcant differences were
found between them in any of the hemostatic parameters
determined.
Despite that fact, when speciﬁc cut-off values were
compared, only 0.9% of medical obstructive cases had
plasma D-Dimer concentrations on admission
45,000 ng/mL, compared with 5.4% in the surgical
group (P 5 .04). Comparing horses with ischemic disor-
ders, a tendency toward signiﬁcance (P o .06) was seen
for higher plasma D-Dimer concentration on admission
in ischemic cases that needed intestinal resection com-
pared with those in which this procedure was not
Table 1. Outcome distribution of horses with different diagnoses.
Survivors (n5 387) Nonsurvivors (n5 80) Financial Restraints (n5 26)
Medical obstructions 211 (54.5%) 2 (2.5%) 16 (61.5%)
Surgical obstructions 67 (17.3%) 7 (8.8%) 0 (0.0%)
Ischemia without intestinal resection 25 (6.5%) 4 (5.0%) 4 (15.4%)
Ischemia with intestinal resection 23 (5.9%) 25 (31.3%) 3 (11.5%)
Enteritis 55 (14.2%) 17 (21.3%) 2 (7.7 %)
Peritonitis 6 (1.6%) 25 (31.3%) 1 (3.9%)
100% 100% 100%
Numbers correspond to absolute number of horses regarding the outcome and percentages to the relative proportion in the same outcome
group and within the different diagnostic groups.
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necessary (Table 3). Furthermore, when speciﬁc cut-off
values were compared, most (90.3%) ischemic cases
without intestinal resection had plasma D-Dimer con-
centrations on admission 2,000 ng/mL, compared with
66.7% in the resection group (P 5 .017). Differences in
other parameters were not signiﬁcant.
The distribution of horses by number of altered
parameters in the coagulation proﬁle by diagnostic group
is shown in Table 4. Horses with enteritis, ischemic
lesions that needed intestinal resection, and peritonitis
had a higher number of coagulopathies, and clinico-
pathological DIC already was diagnosed on admission
in horses with enteritis and peritonitis (10.8 and 9.4%,
respectively).
Hemostatic Proﬁle in the Different Outcome Groups
Results of coagulation proﬁle data by outcome groups
are presented in Table 5. Plasma D-Dimer concentration
was marked and signiﬁcantly (Po .001) higher in dead/
euthanized horses than in discharged horses. Further-
more, 74.2% of survivors had plasma D-Dimer
concentrations within the normal range (1,000 ng/mL)
compared with 35% of nonsurvivors (odds ratio [OR],
5.33; 95% conﬁdence interval [CI], 3.19–8.9, P o .001).
PT also was signiﬁcantly (P o .001) prolonged in non-
survivors, and the percentage of horses with PT 4 15
seconds also was higher in nonsurvivors (OR, 1.9; 95%
CI, 1.1–3.5, P 5 .03). Antithrombin activity was signiﬁ-
cantly (P o .001) lower in dead/euthanized horses than
in discharged ones, and signiﬁcantly more animals with
poor prognosis had AT o 140% (OR, 14.7; 95% CI,
5.5–39.1, Po .001). Differences were not signiﬁcant for
aPTT.
Regarding the type of coagulopathy, there were
signiﬁcantly (P 5 .009) more horses with clinicopatho-
logical DIC (3 coagulopathies) upon presentation in
nonsurvivors (11.3%) than in survivors (3.6%) (Table 6).
Table 3. Distribution of coagulation proﬁle data for different cut-off values (normal or abnormal values) in the main
diagnostic groups.
Cut-off Values
Controls
(n5 30)
Medical
Obstructions
(n5 229)
Surgical
Obstructions
(n5 74)
Ischemic without
Resection
(n5 33)
Ischemic with
Resection
(n5 51)
Enteritis
(n5 74)
Peritonitis
(n5 32)
D-Dimer concentration (ng/mL)
o1,000 29 (96.7%) 181 (79%) 57 (77%) 23 (69.7%) 25 (49%) 38 (51.4%) 6 (18.7%)
41,000 1 (3.3%) 48 (21%) 17 (23%) 10 (30.3%) 26 (51%) 36 (48.6%) 26 (81.3%)
42,000 0 (0%) 22 (10.3%) 10 (13.5%) 3 (9.7%)# 16 (33.3%),# 26 (36.1%) 20 (66.7%)
43,000 0 (0%) 10 (4.7%) 7 (9.5%) 3 (9.7%) 10 (20.8%) 12 (16.7%) 17 (56.7%)
44,000 0 (0%) 7 (3.3%) 6 (8.1%) 3 (9.7%) 7 (14.6%) 7 (9.7%) 16 (53.3%)
45,000 0 (0%) 2 (0.9%)# 4 (5.4%)# 1 (3.2%) 2 (4.2%) 3 (4.2%) 9 (30%)
PT (seconds)
o15 30 (100%) 198 (86.5%) 63 (85.1%) 29 (87.9%) 44 (86.3%) 56 (75.7%) 24 (75%)
415 0 (0%) 31 (13.5%) 11 (14.9%) 4 (12.1%) 7 (13.7%) 18 (24.3%) 8 (25%)
APTT (seconds)
o65 30 (100%) 197 (86%) 64 (86.5%) 29 (87.9%) 41 (80.4%) 59 (79.7%) 26 (81.3%)
465 0 (0%) 32 (14%) 10 (13.5%) 4 (12.1%) 10 (19.6%) 15 (20.3%) 6 (18.8%)
AT (%)
4140 30 (100%) 226 (98.7%) 71 (95.9%) 33 (100%) 48 (94.1%) 66 (89.2%) 27 (84.4%)
o140 0 (0%) 3 (1.3%) 3 (4.1%) 0 (0%) 3 (5.9%) 8 (10.8%) 5 (15.6%)
Results show the number of horses and the percentage in regard to the diagnosis group.
Statistically signiﬁcant when compared with controls.
#Statistically signiﬁcant when compared between diagnostic subgroups (for the obstructive and the ischemic groups).
Table 2. Coagulation proﬁle results obtained on presentation among the different diagnostic groups.
Controls
(n5 30)
Medical
Obstructions
(n5 229)
Surgical
Obstructions
(n5 74)
Ischemic without
Resection
(n5 33)
Ischemic with
Resection
(n5 51)
Enteritis
(n5 74)
Peritonitis
(n5 32)
D-Dimer concentration (ng/mL) 695.0 308.0 419.5 521.0 1,241.8 1,048.3 4,204.0
[586; 742] [133; 923] [168.5; 919.5] [135; 1,212] [360; 2,687] [435; 2,711] [1,652.5; 5,923]
PT (seconds) 11.05 12.1 12.3 12.7 12.9 13.6 13.9
[10.85; 11.4] [11.3; 13.8] [11.2; 14] [11.6; 13.8] [11.6; 14.6] [12.1; 15.6] [13.0; 15.1]
aPTT (seconds) 39.0 50.2 50.9 49.3 51.3 55.3 54.7
[36.9; 41.2] [44.7; 59.7] [44.8; 60.1] [46.0; 58.0] [44.2; 61.6] [49.5; 64.1] [46.0; 61.5]
AT (%) 188.2 214 220 208 201 192 164
[172; 211] [196; 234] [198; 244] [181; 230] [177; 220] [166; 214] [144; 204]
Results are expressed as median [interquartile range: P25th; P75th].
Statistically signiﬁcant (Po .001) when compared with the control group.
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Using the univariate logistic regression model, horses
with 1 or 2 coagulopathies on presentation were more
likely to die (OR, 5.3; 95% CI, 3.0–9.4, Po .001). When
horses had clinicopathological evidence of DIC (3 or 4
of 4 abnormal parameters) on presentation, the OR
value for mortality increased to 8.6 (95% CI, 3.3–22.5,
Po .001).
Results of the Positive Likelihood Ratios and Logistic
Regression Models
D-Dimer concentrations of approximately 4,000 ng/
mL showed a LR1 value of 5.9 for dying/being euthani-
zed. No optimal interval of results to suggest potentially
useful cut-off values was identiﬁed for the remaining
parameters (results not shown). The logistic regression
model including plasma D-Dimer concentration (crude
analysis) resulted in an OR of 8.78 (95% CI, 4.52–17.05,
P o .001) for nonsurvival when values were approxi-
mately 4,000 ng/mL. Adjusted OR for D-Dimer
concentration (44,000 ng/mL) by mean PT (415 sec-
onds), aPTT (465 seconds), or AT (o140%) did not
show substantial changes from crude OR evaluation of
D-Dimer analysis. Only AT valueso140%maintained a
signiﬁcant effect in the presence of the D-Dimer factor.
Discussion
The most common coagulopathy in horses with colic is
a hypercoagulable state that can progress to DIC. The
intensity of this coagulopathy will depend on the severity
and duration of the GI lesion, with ischemic and inﬂam-
matory problems and peritonitis being most frequently
affected by coagulopathies.6,35 Furthermore, the severity
of coagulopathies in horses with GI problems also seems
to be associated with poor outcome.3,5,7,9 In the present
study, plasma D-Dimer concentration was related to di-
agnosis and prognosis, which could help to differentiate
horses with enteritis and peritonitis from other diag-
noses, and especially to detect horses with poor
outcome. Furthermore, D-Dimer concentration was the
most sensitive coagulation parameter for these diagnos-
tic and prognostic purposes of the parameters tested in
the present study.
Regarding diagnosis, results of this study indicate that
patients with enteritis or peritonitis had signiﬁcantly
higher D-Dimer concentration when tested on presenta-
tion, AT was signiﬁcantly lower and alterations in
hemostatic parameters were more severe. These 2 diag-
nostic groups also included a higher percentage of horses
with subclinical DIC on admission. In the literature,
inﬂammatory and ischemic conditions are the diagnoses
most often associated with severe coagulopathies,
Table 4. Distribution of horses by number of coagulopathies detected on presentation in the different diagnostic
groups.
Number of Abnormal Hemostatic Parameters (out of 4)
Medical
Obstructions
(n5 229)
Surgical
Obstructions
(n 5 74)
Ischemic without
Resection
(n5 33)
Ischemic with
Resection
(n5 51)
Enteritis
(n5 74)
Peritonitis
(n5 32)
Normal proﬁle 157 44 20 18 27 4
(68.3%) (59.5%) (60.6%) (35.3%) (36.5%) (12.5%)
Activated coagulation system (1 or 2 abnormal parameters) 61 29 12 31 39 25
(26.6%) (39.2%) (36.4%) (60.8%) (52.7%) (78.1%)
Subclinical DIC (3 abnormal parameters) 11 1 1 2 8 3
(4.8%) (1.4%) (3%) (3.9%) (10.8%) (9.4%)
The numbers correspond to absolute number of horses and percentages to the relative proportion in the diagnostic groups.
Table 5. Results of the coagulation proﬁle in the main outcome groups (survivors and nonsurvivors).
Survivors
(n5 387)
Nonsurvivors
(n5 80)
Cut-off
Values Survivors Nonsurvivors
OR
(95% CI)
P-Value
D-Dimer concentration (ng/mL) 383
[143; 1,112]
2,304
[733; 4,489]
1,000 74.2% 35.0% 5.33 (3.19–8.9)
Po .00141,000 25.8% 65.0%
4,000 94.8% 67.5% 8.78 (4.52–17.05)
Po .00144,000 5.2% 32.5%
PT (seconds) 12.3 13.8 o15 86% 76.3% 1.9 (1.1–3.5)
P5 .03[11.3; 13.9] [12.0; 15.1] 415 14% 23.8%
APTT (seconds) 50.7 54.7 o65 85.5% 80% 1.5 (0.8–2.7)
P5 .21[45.3; 60.7] [44.4; 61.0] 465 14.5% 20%
AT (%) 212 192 4140 98.4% 81.3% 14.7 (5.5–39.1)
Po .001[190; 234] [144; 212] o140 1.6% 18.8%
Results are expressed as median [interquartile range: P25th; P75th]. Distribution (percentage) of these coagulation data for different cut-off
values in the main outcome groups is shown, as well as the OR for the corresponding cut-off value.
Statistically signiﬁcant (Po .001) when compared with survivors for quantitative results.
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especially when diagnosed during hospitalization.7,8,10,37
In the present study, however, severe coagulopathies
were detected upon presentation. In horses with colic
and in septic foals, the inﬂammatory response, and con-
sequently activation of the coagulation system, can be
more severe some hours after presentation,a,c,7,34,36
which could explain why abnormalities of the coagula-
tion proﬁle detected on admission usually are milder. In
addition, in the present study D-Dimer concentration in
ischemic disorders taken as a whole was not signiﬁcantly
higher on admission, although a tendency toward signiﬁ-
cance (P5 .06) was present when comparing horses with
or without resection, with D-Dimer concentration higher
in horses that needed enterectomy. Previous studies also
suggest that D-Dimer concentrations in ischemic colicky
horses tend to increase early after admission.a,c Thus, the
lack of signiﬁcance in the group that needed intestinal
resection could be associated with the fact that samples
were taken too early in the ischemic process.
Regarding diagnosis, when speciﬁc concentrations of
D-Dimers were analyzed, one third of ischemic horses
with intestinal resection had plasma D-Dimer concentra-
tions on admission of 42,000 ng/mL, compared with
just 10% of horses in which intestinal resection was not
necessary. This additional information can help the
clinician determine prognosis and treatment when
confronted with such types of colic. In contrast, in
obstructive colics there were signiﬁcantly more horses
with plasma D-Dimer concentrations on admission
45,000 ng/mL in the surgical group compared with the
medical group. Most horses in both groups (94.6 and
99.1%, respectively), however, had lower concentrations,
which limits the applicability of this information in a
clinical setting. Clotting times also showed signiﬁcant
differences when compared with controls, but not be-
tween medical and surgical obstructions or ischemic
problems with or without resection. Finally, AT did
not show signiﬁcant differences for the cut-off values
applied.
Enteritis and peritonitis were the diagnoses with the
higher prevalence of subclinical DIC upon admission
and, together with ischemic lesions (especially those re-
quiring resection), had the highest number of patients
with activation of the coagulation system. These ﬁndings
are in accordance with previous studies.6,7,35 Thus, these
severe inﬂammatory conditions seem to be linked to se-
vere coagulopathies, which are already detected on
admission when using sensitive tests. Other diagnoses
(such as ischemic disorders) would need to be retested
after presentation or by use of a larger coagulation pro-
ﬁle to better assess the associated coagulopathy.
In general, diagnoses corresponding to more severe
disorders, most commonly associated with nonsurvival,
also had the highest percentage of horses with the highest
D-Dimer concentrations.
Several studies have attempted to elucidate the role
of coagulation abnormalities with fatality during
colic.a,c,3,9,11,20,21,23,29 One of the objectives of this study
was to evaluate the usefulness of admission results of
several hemostatic parameters to predict the likelihood
of survival. In this study, plasma D-Dimer concentra-
tions on presentation were signiﬁcantly higher, PT
signiﬁcantly prolonged and AT signiﬁcantly lower in
nonsurvivors than in survivors. However, while most
nonsurvivors had markedly increased D-Dimer concen-
trations (41,000 ng/mL), a lower percentage of
nonsurvivors had PT and AT results above the reference
range (415 seconds and o140%, respectively). Thus,
according to these results, D-Dimer concentration seems
to be more associated with prognosis than the remaining
coagulation variables tested. Other studies in horses with
colic also found higher D-Dimer concentrations in non-
survivors,21 as well as prolonged PT and decreased AT,
thus conﬁrming these results.3,5,7,9,11,29
Horses with plasma D-Dimer concentrations on ad-
mission 41,000 ng/mL and 44,000 ng/mL were found
to be 5.33 and 8.78 times more likely to die, respectively.
This information can be useful to the clinician to predict
outcome in a case of colic. Furthermore, horses with AT
results below 140% had 14.7 times more probability of
nonsurvival. Nevertheless, results of AT are rarely below
this level, even in severe colics, and so this information
has little clinical value. In contrast, PT did not show a
good predictive value for nonsurvival (OR 5 1.9). Thus,
following our results, D-Dimer concentration could
have better prognostic value than the other coagulation
parameters tested.
When the coagulopathies were assessed for outcome,
there were signiﬁcantly more horses with subclinical DIC
(3 altered parameters) in the group of nonsurvivors.
Furthermore, horses had 8.6 times more probability to
die if they were in subclinical DIC, and 5.3 times more
probability if they only had 1 or 2 abnormal coagulation
parameters. This ﬁnding is not surprising because the
Table 6. Distribution of horses by number of coagulopathies detected on presentation in the different outcome
groups.
Number of Abnormal Hemostatic Parameters on Admission (out of 4)
Survivors
(n 5 387)
Nonsurvivors
(n 5 80)
OR
(95% CI) P-Value
Normal proﬁle 240 18 Baseline
(62.0%) (22.5%)
Coagulation system activated (1 or 2 abnormal parameters) 133 53 5.3 (3.0–9.4) o.001
(34.4%) (66.3%)
Subclinical DIC (3 abnormal parameters) 14 9 8.6 (3.3–22.5) o.001
(3.6%) (11.3%)
The numbers correspond to absolute number of horses and percentages to the relative proportion in the outcome groups.
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literature reports worse outcomes in horses with GI
problems associated with a high number of coagulopat-
hies and DIC.3,7,9,10 Postmortem studies also found
higher ﬁbrin deposition scores in different organs of
horses with colic diagnoses more commonly associated
with DIC.8,38 Nevertheless, previous results complemen-
tary with this study conﬁrm that alterations of the
coagulation proﬁle in horses that survived tend to
normalize during hospitalization regardless of the
diagnosis.a
Our results have shown that changes in hemostasis are
frequent in severe GI disorders of horses. D-Dimer con-
centration determined on presentation has a clear
relationship with outcome. Results of the LR1 in this
population of colic horses conﬁrmed that plasma D-
Dimer concentration is a sensitive parameter, with con-
centrations on admission 44,000 ng/mL indicating a
moderate to marked increase in the likelihood of dying
or being euthanized. This analysis is very similar to ROC
curves and area under curve calculations and can be used
for equivalent purposes to determine the diagnostic and
prognostic utility of a test in different diseases. The LR1
for death used in the present study has the advantage of
offering the same optimal cut-off point as does graphical
evaluation of the ROC curve, but also considers the
goodness of the cut-off point. Furthermore, the logistic
regression models combining AT and plasma D-Dimer
concentration showed the best LR1 with D-Dimer con-
centrations to be approximately 4,000 ng/mL. Therefore,
based on this study, if a D-Dimer cut-off concentration
of 4,000 ng/mL is used on admission, the likelihood ratio
of death independently of diagnosis is approximately 6 : 1
(ie, 6 horses with D-Dimer concentration44,000 ng/mL
are likely to die for each horse with D-Dimer concentra-
tion 44,000 ng/mL that survives). In contrast, other
studies have not found that D-Dimer concentrations
provide any additional information in explaining out-
come when tested on admission, but they used less
accurate methods in a smaller population of horses.7,20
One possible limitation of this study is that the number
of hemostatic parameters determined was low, and did
not include platelet count or other commonly tested
parameters characterized by their low sensitivity. Never-
theless, the parameters determined in this study are those
currently used in humans and dogs to evaluate coagulo-
pathies and constitute the basis of DIC scoring systems in
these species or are used to increase diagnostic sensitiv-
ity.39–41 With such a low number of parameters tested,
identiﬁcation of coagulopathies and diagnosis of DIC
could be limited. However, the percentage of coagulo-
pathies and diagnosis of DIC ﬁnally detected in the
present study was similar to what has been reported in
other studies in which more hemostatic parameters were
tested.
In conclusion, the present study conﬁrmed that when a
simple hemostatic proﬁle that includes D-Dimer concen-
tration was assessed on admission in horses with colic,
the most severe coagulopathies were observed in horses
with the most severe forms of GI disorders (eg, inﬂam-
matory conditions, ischemic intestinal problems that
needed intestinal resection, peritonitis) and in nonsurvi-
vors. Furthermore, the diagnoses with higher percentage
of nonsurvival also had more horses with high concen-
trations of D-Dimers. Moreover, this study also supports
the usefulness of D-Dimer concentration tested on ad-
mission to predict outcome in horses with GI disorders,
especially when 44,000 ng/mL. Additional studies are
warranted using this cut-off value in a different popula-
tion of horses to conﬁrm its possible diagnostic and
prognostic value.
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